SavedAdd your journal

Journals / İstanbul Medical Journal / 2019 / Cilt: 20 - Sayı: 1

Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients

Nötrofil Lenfosit Oranı İmmün Trombositopeni Hastalarında Kortikosteroid Tedavisine Yanıtı Öngörebilir mi?

Mehmet ÜNALDI
Abdülkadir KARIŞMAZ
Hilal TAN KÖKER
Şermin ALTINDAL
Mehmet Hilmi DOĞU
Osman YOKUŞ
Rafet EREN
Elif SUYANI
Pages
54–57
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The cut-off score for NLR wasdetermined at 2.5 according to median NLR level.Results: Twenty-three (48.9%) patients had NLR

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: We aimed to investigate the associationbetween neutrophil lymphocyte ratio (NLR) and responseand loss of response to corticosteroid treatment in immunethrombocytopenia patients (ITP).Methods: We retrospectively analyzed the data of 47 ITPpatients treated with corticosteroid therapy at Istanbul Trainingand Research Hospital Clinic of Hematology between 2007and 2016.
📊
Key Findings & Data:NLR was calculated using complete blood count ofpatients at the time of diagnosis.
💡
Conclusion & Impact:The cut-off score for NLR wasdetermined at 2.5 according to median NLR level.Results: Twenty-three (48.9%) patients had NLR
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: We aimed to investigate the associationbetween neutrophil lymphocyte ratio (NLR) and responseand loss of response to corticosteroid treatment in immunethrombocytopenia patients (ITP).Methods: We retrospectively analyzed the data of 47 ITPpatients treated with corticosteroid therapy at Istanbul Trainingand Research Hospital Clinic of Hematology between 2007and 2016. NLR was calculated using complete blood count ofpatients at the time of diagnosis. The cut-off score for NLR wasdetermined at 2.5 according to median NLR level.Results: Twenty-three (48.9%) patients had NLR

Özet

Amaç: Bu çalışmada immün trombositopeni (ITP) hastalarında nötrofil lenfosit oranı (NLO) ile kortikosteroid tedavisine yanıt ve yanıt kaybı arasındaki ilişkiyi araştırmayı amaçladık. Yöntemler: 2007 ile 2016 yılları arasında İstanbul Eğitim ve Araştırma Hastanesi Hematoloji Kliniğinde kortikosteroid ile tedavi edilmiş 47 ITP hastasının verileri retrospektif olarak incelendi. NLO, hastaların tanı anındaki hemogramları kullanılarak hesaplandı. Medyan NLO düzeyine göre NLO için eşik değer 2,5 olarak belirlendi. Bulgular: Yirmi üç hastada (%48,9) NLO

🔖

Cite This Article

ÜNALDI, M., KARIŞMAZ, A., KÖKER, H. T., ALTINDAL, Ş., DOĞU, M. H., YOKUŞ, O., EREN, R., SUYANI, E. (2022). Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients. İstanbul Medical Journal, Cilt: 20 - Sayı: 1, 54–57. https://ajindex.com/articles/551945

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-207
  2. Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 2008; 99: 4-13
  3. Psaila B, Bussel JB. Refractory immune thrombocytopenic purpura: current strategies for investigation and management. Br J Haematol 2008; 143: 16-26
  4. Cuker A, Neunert CE. How I treat refractory immune thrombocytopenia. Blood 2016; 128: 1547-54
  5. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 2244-51
  6. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012; 5: 2
  7. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4: 221-33
  8. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013; 11: 55-9
  9. Li L, Xia Y, Chen C, Cheng P, Peng C. Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 2015; 8: 11026-31
  10. Uslu AU, Küçük A, Şahin A, Ugan Y, Yılmaz R, Güngör T, et al. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and plateletlymphocyte ratio. Int J Rheum Dis 2015; 18: 731-5
  11. Rifaioglu EN, Bülbül Şen B, Ekiz Ö, Cigdem Dogramaci A. Neutrophil to lymphocyte ratio in Behçet’s disease as a marker of disease activity. Acta Dermatovenerol Alp Pannonica Adriat 2014; 23: 65-7
  12. Alan S, Tuna S, Türkoğlu EB. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci 2015; 31: 626-31
  13. Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol 2016; 43: 305-10
  14. Ataseven A, Bilgin AU, Kurtipek GS. The importance of neutrophil lymphocyte ratio in patients wit